PLA2G16 Antikörper (AA 1-132) (HRP)
-
- Target Alle PLA2G16 Antikörper anzeigen
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
-
Bindungsspezifität
- AA 1-132
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLA2G16 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human HRAS-like suppressor 3 protein (1-132AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PLA2G16 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PLA2G16 (HRAS-Like Suppressor 3 (PLA2G16))
- Andere Bezeichnung
- PLA2G16 (PLA2G16 Produkte)
- Synonyme
- HRASLS3 antikoerper, HREV107 antikoerper, HRSL3 antikoerper, AdPLA antikoerper, H-REV107-1 antikoerper, HREV107-1 antikoerper, HREV107-3 antikoerper, C78643 antikoerper, Hrasls3 antikoerper, Hrev107 antikoerper, MLP-3 antikoerper, phospholipase A2 group XVI antikoerper, phospholipase A2, group XVI antikoerper, PLA2G16 antikoerper, Pla2g16 antikoerper
- Hintergrund
-
Background: Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.
Aliases: Adipose specific phospholipase A2 antibody, Adipose specific PLA2 antibody, Adipose-specific phospholipase A2 antibody, AdPLA antibody, Ca independent phospholipase A1/2 antibody, Group XVI phospholipase A1/A2 antibody, Group XVI phospholipase A2 antibody, H rev 107 protein homolog antibody, H REV107 1 antibody, H-rev 107 protein homolog antibody, HRAS like suppressor 1 antibody, HRAS like suppressor 3 antibody, HRAS-like suppressor 1 antibody, HRAS-like suppressor 3 antibody, HREV107 1 antibody, HREV107 3 antibody, HREV107 antibody, HREV107-1 antibody, HREV107-3 antibody, HRSL3 antibody, HRSL3_HUMAN antibody, Phospholipase A2 group XVI antibody, Pla2g16 antibody, Renal carcinoma antigen NY REN 65 antibody, Renal carcinoma antigen NY-REN-65 antibody
- UniProt
- P53816
- Pathways
- Inositol Metabolic Process
-